Author Correction: Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cell

Yulong Gao^#^{1

2}, Fernando Souza-Fonseca-Guimaraes^#^{1

3

4}, Tobias Bald¹, Susanna S Ng^{5

6}, Arabella Young^{1

2}, Shin Foong Ngiow¹, Jai Rautela³, Jasmin Straube⁷, Nic Waddell⁷, Stephen J Blake⁸, Juming Yan^{2

8}, Laurent Bartholin⁹, Jason S Lee¹⁰, Eric Vivier¹¹, Kazuyoshi Takeda¹², Meriem Messaoudene^{13

14}, Laurence Zitvogel^{14

15

16}, Michele W L Teng^{2

8}, Gabrielle T Belz³, Christian R Engwerda⁵, Nicholas D Huntington³, Kyohei Nakamura¹, Michael Hölzel¹⁷, Mark J Smyth^{18

19}

Affiliations

¹ Immunology in Cancer and Infection, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.
² School of Medicine, The University of Queensland, Herston, Queensland, Australia.
³ Molecular Immunology Division, The Walter and Eliza Hall Institute of Medical Research, Department of Medical Biology and The University of Melbourne, Parkville, Victoria, Australia.
⁴ Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Melbourne, Victoria, Australia.
⁵ Immunology and Infection, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.
⁶ School of Natural Sciences, Griffith University, Nathan, Queensland, Australia.
⁷ Medical Genomics, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.
⁸ Cancer Immunoregulation and Immunotherapy, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.
⁹ Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Centre de recherche en cancérologie de Lyon, Lyon, France.
¹⁰ Control of Gene Expression Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.
¹¹ Centre d'Immunologie de Marseille-Luminy, Aix Marseille Université, INSERM, CNRS, Marseille, France.
¹² Division of Cell Biology, Biomedical Research Center and Department of Biofunctional Microbiota, Graduate School of Medicine, Juntendo University, Bunkyo-ku, Tokyo, Japan.
¹³ INSERM U1015, Gustave Roussy Cancer Campus, Villejuif, France.
¹⁴ Gustave Roussy Cancer Campus, Villejuif, France.
¹⁵ University Paris-Saclay, Kremlin Bicêtre, Paris, France.
¹⁶ CIC1428, Gustave Roussy Cancer Campus, Villejuif, France.
¹⁷ Unit for RNA Biology, Department of Clinical Chemistry and Clinical Pharmacology, University of Bonn, Bonn, Germany.
¹⁸ Immunology in Cancer and Infection, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia. mark.smyth@qimrberghofer.edu.au.
¹⁹ School of Medicine, The University of Queensland, Herston, Queensland, Australia. mark.smyth@qimrberghofer.edu.au.

^# Contributed equally.

PMID: 38514890
DOI: 10.1038/s41590-024-01799-9

Published Erratum

Author Correction: Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cell

Yulong Gao et al. Nat Immunol. 2024 May.

. 2024 May;25(5):925-926.

doi: 10.1038/s41590-024-01799-9.

Authors

Affiliations

¹ Immunology in Cancer and Infection, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.
² School of Medicine, The University of Queensland, Herston, Queensland, Australia.
³ Molecular Immunology Division, The Walter and Eliza Hall Institute of Medical Research, Department of Medical Biology and The University of Melbourne, Parkville, Victoria, Australia.
⁴ Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Melbourne, Victoria, Australia.
⁵ Immunology and Infection, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.
⁶ School of Natural Sciences, Griffith University, Nathan, Queensland, Australia.
⁷ Medical Genomics, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.
⁸ Cancer Immunoregulation and Immunotherapy, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.
⁹ Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Centre de recherche en cancérologie de Lyon, Lyon, France.
¹⁰ Control of Gene Expression Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.
¹¹ Centre d'Immunologie de Marseille-Luminy, Aix Marseille Université, INSERM, CNRS, Marseille, France.
¹² Division of Cell Biology, Biomedical Research Center and Department of Biofunctional Microbiota, Graduate School of Medicine, Juntendo University, Bunkyo-ku, Tokyo, Japan.
¹³ INSERM U1015, Gustave Roussy Cancer Campus, Villejuif, France.
¹⁴ Gustave Roussy Cancer Campus, Villejuif, France.
¹⁵ University Paris-Saclay, Kremlin Bicêtre, Paris, France.
¹⁶ CIC1428, Gustave Roussy Cancer Campus, Villejuif, France.
¹⁷ Unit for RNA Biology, Department of Clinical Chemistry and Clinical Pharmacology, University of Bonn, Bonn, Germany.
¹⁸ Immunology in Cancer and Infection, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia. mark.smyth@qimrberghofer.edu.au.
¹⁹ School of Medicine, The University of Queensland, Herston, Queensland, Australia. mark.smyth@qimrberghofer.edu.au.

^# Contributed equally.

PMID: 38514890
DOI: 10.1038/s41590-024-01799-9

No abstract available

PubMed Disclaimer

Erratum for

Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cells.
Gao Y, Souza-Fonseca-Guimaraes F, Bald T, Ng SS, Young A, Ngiow SF, Rautela J, Straube J, Waddell N, Blake SJ, Yan J, Bartholin L, Lee JS, Vivier E, Takeda K, Messaoudene M, Zitvogel L, Teng MWL, Belz GT, Engwerda CR, Huntington ND, Nakamura K, Hölzel M, Smyth MJ. Gao Y, et al. Nat Immunol. 2017 Sep;18(9):1004-1015. doi: 10.1038/ni.3800. Epub 2017 Jul 31. Nat Immunol. 2017. PMID: 28759001

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Author Correction: Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cell

Affiliations

Author Correction: Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cell

Authors

Affiliations

Erratum for

Publication types

LinkOut - more resources

Full Text Sources